Cargando…

How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications

Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is a popular treatment for actinic keratoses (AK), and several PDT treatment modalities with similar cure rates are in use. The effect relies on the activation of protoporphyrin IX (PpIX) in premalignant cells. This study aimed to measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Wulf, Hans Christian, Heerfordt, Ida M., Philipsen, Peter Alshede
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067410/
https://www.ncbi.nlm.nih.gov/pubmed/33917339
http://dx.doi.org/10.3390/ph14040333
_version_ 1783682796757188608
author Wulf, Hans Christian
Heerfordt, Ida M.
Philipsen, Peter Alshede
author_facet Wulf, Hans Christian
Heerfordt, Ida M.
Philipsen, Peter Alshede
author_sort Wulf, Hans Christian
collection PubMed
description Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is a popular treatment for actinic keratoses (AK), and several PDT treatment modalities with similar cure rates are in use. The effect relies on the activation of protoporphyrin IX (PpIX) in premalignant cells. This study aimed to measure PpIX during each treatment modality to determine the minimal PpIX activation and shortest exposure time for optimal cure rate. In four different treatment modalities, we established the PpIX formation up to three hours after MAL application without illumination and measured the speed of PpIX photoactivation during 9 min of red light (37 J/cm(2)). The level of PpIX three hours after MAL application was set to 100 PpIX units. In comparison, 85 PpIX units were formed during daylight PDT, 57 PpIX units during pulse PDT, and 52 PpIX units without any curettage prior to MAL. The activation of 50 PpIX units should, therefore, be enough to obtain a full effect on AK. Further, red light illumination may be shortened from 9 min to 1–2 min. The results indicate that PDT can be performed successfully with half the illumination time used in daylight PDT today and with one fourth of the illumination time used in classical PDT.
format Online
Article
Text
id pubmed-8067410
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80674102021-04-25 How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications Wulf, Hans Christian Heerfordt, Ida M. Philipsen, Peter Alshede Pharmaceuticals (Basel) Article Photodynamic therapy (PDT) with methyl aminolevulinate (MAL) is a popular treatment for actinic keratoses (AK), and several PDT treatment modalities with similar cure rates are in use. The effect relies on the activation of protoporphyrin IX (PpIX) in premalignant cells. This study aimed to measure PpIX during each treatment modality to determine the minimal PpIX activation and shortest exposure time for optimal cure rate. In four different treatment modalities, we established the PpIX formation up to three hours after MAL application without illumination and measured the speed of PpIX photoactivation during 9 min of red light (37 J/cm(2)). The level of PpIX three hours after MAL application was set to 100 PpIX units. In comparison, 85 PpIX units were formed during daylight PDT, 57 PpIX units during pulse PDT, and 52 PpIX units without any curettage prior to MAL. The activation of 50 PpIX units should, therefore, be enough to obtain a full effect on AK. Further, red light illumination may be shortened from 9 min to 1–2 min. The results indicate that PDT can be performed successfully with half the illumination time used in daylight PDT today and with one fourth of the illumination time used in classical PDT. MDPI 2021-04-06 /pmc/articles/PMC8067410/ /pubmed/33917339 http://dx.doi.org/10.3390/ph14040333 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wulf, Hans Christian
Heerfordt, Ida M.
Philipsen, Peter Alshede
How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title_full How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title_fullStr How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title_full_unstemmed How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title_short How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications
title_sort how much protoporphyrin ix must be activated to obtain full efficacy of methyl aminolevulinate photodynamic therapy? implication for treatment modifications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067410/
https://www.ncbi.nlm.nih.gov/pubmed/33917339
http://dx.doi.org/10.3390/ph14040333
work_keys_str_mv AT wulfhanschristian howmuchprotoporphyrinixmustbeactivatedtoobtainfullefficacyofmethylaminolevulinatephotodynamictherapyimplicationfortreatmentmodifications
AT heerfordtidam howmuchprotoporphyrinixmustbeactivatedtoobtainfullefficacyofmethylaminolevulinatephotodynamictherapyimplicationfortreatmentmodifications
AT philipsenpeteralshede howmuchprotoporphyrinixmustbeactivatedtoobtainfullefficacyofmethylaminolevulinatephotodynamictherapyimplicationfortreatmentmodifications